Preoperative Functional Connectivity Predicts Antiparkinson Drug Change after Deep Brain Stimulation.

IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY
David Mikhael,Skyler Deutsch,Juhi Mehta,Sarah Wang,John Kornak,Philip A Starr,Jill L Ostrem,Doris D Wang,Ian O Bledsoe,Melanie A Morrison
{"title":"Preoperative Functional Connectivity Predicts Antiparkinson Drug Change after Deep Brain Stimulation.","authors":"David Mikhael,Skyler Deutsch,Juhi Mehta,Sarah Wang,John Kornak,Philip A Starr,Jill L Ostrem,Doris D Wang,Ian O Bledsoe,Melanie A Morrison","doi":"10.1002/mds.70063","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nDeep brain stimulation (DBS) can effectively ameliorate motor symptoms in Parkinson's disease (PD), but patient outcomes remain variable. Clinical predictors lack reliability and only explain a small proportion of outcome variance, outlining a need for biomarkers that can enhance prediction accuracy. Functional magnetic resonance imaging (fMRI) could address this, offering insight into the relative impact of functional brain health on DBS outcomes.\r\n\r\nMETHODS\r\nPreoperative resting-state fMRI was retrospectively collected for 120 patients with PD and DBS targeting the subthalamic nucleus or pallidum. Motor network connectivity was computed, and clinical predictors extracted including age, sex, target, hemisphere treated, and preoperative medication responsiveness. Pre-to-post changes in antiparkinson medications defined outcomes. Regression analysis selected important connectivity features and evaluated additional outcome variance explained by fMRI when combined with clinical predictors. Last, classification analysis assessed fMRI feature specificity to PD compared to Huntington's disease and healthy controls.\r\n\r\nRESULTS\r\nAlongside clinical predictors, fMRI features explained more outcome variance (R2 adjusted = 0.36) than clinical predictors alone (R2 adjusted = 0.13). Five connectivity pairs bridging the cortico-basal ganglia-cerebellar network were predictive of outcomes and distinguished PD from controls and Huntington's disease with reasonable accuracy (67% and 73%). Exploratory analysis revealed that intracerebellar connectivity, although a less stable predictor of DBS outcomes, dramatically increased PD classification accuracy (≥98%).\r\n\r\nCONCLUSION\r\nPatient-specific motor connectivity enhances DBS outcome prediction and could aid detection and monitoring of basal ganglia disorders. Future work will validate and extend our models for multi-parameter MR prediction of standardized outcomes, toward the development of decision support tools for DBS. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"18 1","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Movement Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/mds.70063","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Deep brain stimulation (DBS) can effectively ameliorate motor symptoms in Parkinson's disease (PD), but patient outcomes remain variable. Clinical predictors lack reliability and only explain a small proportion of outcome variance, outlining a need for biomarkers that can enhance prediction accuracy. Functional magnetic resonance imaging (fMRI) could address this, offering insight into the relative impact of functional brain health on DBS outcomes. METHODS Preoperative resting-state fMRI was retrospectively collected for 120 patients with PD and DBS targeting the subthalamic nucleus or pallidum. Motor network connectivity was computed, and clinical predictors extracted including age, sex, target, hemisphere treated, and preoperative medication responsiveness. Pre-to-post changes in antiparkinson medications defined outcomes. Regression analysis selected important connectivity features and evaluated additional outcome variance explained by fMRI when combined with clinical predictors. Last, classification analysis assessed fMRI feature specificity to PD compared to Huntington's disease and healthy controls. RESULTS Alongside clinical predictors, fMRI features explained more outcome variance (R2 adjusted = 0.36) than clinical predictors alone (R2 adjusted = 0.13). Five connectivity pairs bridging the cortico-basal ganglia-cerebellar network were predictive of outcomes and distinguished PD from controls and Huntington's disease with reasonable accuracy (67% and 73%). Exploratory analysis revealed that intracerebellar connectivity, although a less stable predictor of DBS outcomes, dramatically increased PD classification accuracy (≥98%). CONCLUSION Patient-specific motor connectivity enhances DBS outcome prediction and could aid detection and monitoring of basal ganglia disorders. Future work will validate and extend our models for multi-parameter MR prediction of standardized outcomes, toward the development of decision support tools for DBS. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
术前功能连通性预测脑深部刺激后抗帕金森药物变化。
脑深部电刺激(DBS)可以有效改善帕金森病(PD)的运动症状,但患者的预后仍然不稳定。临床预测指标缺乏可靠性,只能解释一小部分结果差异,因此需要生物标志物来提高预测准确性。功能性磁共振成像(fMRI)可以解决这个问题,为脑功能健康对DBS结果的相对影响提供深入的见解。方法回顾性收集120例PD和DBS患者手术前静息态功能磁共振成像(fMRI)。计算运动网络连通性,提取临床预测因子,包括年龄、性别、靶、治疗半球和术前药物反应。抗帕金森药物治疗前后的变化定义了结果。回归分析选择了重要的连通性特征,并评估了fMRI与临床预测因子相结合时解释的其他结果方差。最后,分类分析评估与亨廷顿氏病和健康对照相比,PD的fMRI特征特异性。结果除临床预测因子外,fMRI特征比单独的临床预测因子(R2调整= 0.36)解释了更多的结果方差(R2调整= 0.13)。连接皮质-基底神经节-小脑网络的5对连接可以预测预后,并以合理的准确度将PD与对照组和亨廷顿病区分开来(67%和73%)。探索性分析显示,小脑内连通性虽然不是DBS预后的稳定预测指标,但显著提高了PD分类准确率(≥98%)。结论患者特异性运动连通性增强了DBS预后预测,有助于基底神经节疾病的检测和监测。未来的工作将验证和扩展我们的模型,用于标准化结果的多参数MR预测,为DBS开发决策支持工具。©2025作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Movement Disorders
Movement Disorders 医学-临床神经学
CiteScore
13.30
自引率
8.10%
发文量
371
审稿时长
12 months
期刊介绍: Movement Disorders publishes a variety of content types including Reviews, Viewpoints, Full Length Articles, Historical Reports, Brief Reports, and Letters. The journal considers original manuscripts on topics related to the diagnosis, therapeutics, pharmacology, biochemistry, physiology, etiology, genetics, and epidemiology of movement disorders. Appropriate topics include Parkinsonism, Chorea, Tremors, Dystonia, Myoclonus, Tics, Tardive Dyskinesia, Spasticity, and Ataxia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信